Abstract
The cellular requirements for generating potent human CD8+ CTLs to influenza A virus in vitro have been defined. Furthermore, we have developed improved methods for generating large numbers of DCs from non-proliferating progenitors. These developments have enabled the design of new strategies to elicit CTLs in vivo. For example together with IL-12, antigen-pulsed DCs may be a useful approach for boosting CTL responses against infectious agents and malignancies. Our results also reopen the potential use of inactivated virus preparations as immunogens for CTL responses.
Original language | English |
---|---|
Pages (from-to) | 383-387 |
Number of pages | 5 |
Journal | Advances in Experimental Medicine and Biology |
Volume | 417 |
DOIs | |
State | Published - 1997 |
Externally published | Yes |